Risedronate averts breast cancer-related bone loss

NEW YORK (Reuters Health) - Bone loss in women who survive breast cancer after undergoing chemotherapy can be prevented by once-weekly treatment with risedronate, according to the results of a new study. Risedronate, which goes by the brand name ...